Alt-Bionics
Develops affordable, AI-enhanced bionic hands for upper-limb amputees and high-performance end effectors for humanoid robotics using 3D printing.
- CEO / Founder
- Ryan Saavedra
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $2.45M
- Latest Round
- Seed
- Key Investors
- Norfolk State University Innovation Center; City of San Antonio (SAMMI Fund); Alamo Angels; VelocityTX; Capital Factory; Austin Technology Incubator
Technology & Products
Key Products
Alt-Bionics develops high-performance, durable, and cost-effective bionic hands for both amputees and humanoid robots. Their product line includes the Genesis Hand (myoelectric prosthetic bionic hand) and the Surge Hand (robotic hand for humanoid platforms with tactile sensing and ~18kg payload).
Technological Advantage
Cost reduction via 3D printing (MJF) allows for insurance-compatible pricing and accessibility in developing markets.
Differentiation
Value Proposition
Reduces cost of bionic prosthetics to make them accessible/affordable for below-elbow amputees while maintaining high performance (6 degrees of freedom).
How They Differentiate
Focus on affordability and accessibility through 3D printing cost-efficiencies compared to traditional bionic hands.
Market & Competition
Target Customers
Upper-limb amputees (via NGOs, insurance, direct), humanoid robotics firms
Industry Verticals
Medical; Robotics
Competitors
Össur hf, Touch Bionics Inc, Open Bionics
Growth & Milestones
Growth Metrics
1.2M+ social media followers; Customer Acquisition Cost (CAC) <$10; 10 employees; Target product price point of $5,000
Major Milestones
Genesis Hand production via 3D printing (2024); PDAC approval for Genesis Hand with L6880 code (Nov 2024); Surge Hand debut at Humanoids Summit (Dec 2024); Sales to Nvidia, Apptronik, Ultra (Q1 2025); Manus partnership (Feb 2025); Truelimbs partnership for MENA region (Apr 2026); Raising Series A ($4.5M committed of $12M target)
Notable Customers
Nvidia; Apptronik; Ultra; Shirley Ryan Ability Lab